APO RESEARCH · REPORT
Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging
Selected research
Market Outlook & Growth Opportunities
Global Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Market Outlook and Growth Opportunities 2026
Market perspective
The global Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging market include TÜV Rheinland AG, DNV AS, UL Solutions Inc., BSI Group, LRQA Group Limited, DEKRA SE, RINA S.p.A., SCS Global Services and Intertek Group plc, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging market.
Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Segment by Company
TÜV Rheinland AG
DNV AS
UL Solutions Inc.
BSI Group
LRQA Group Limited
DEKRA SE
RINA S.p.A.
SCS Global Services
Intertek Group plc
Eurofins Scientific SE
Sphera Solutions, Inc.
One Click LCA Oy
Ecochain Technologies B.V.
Trayak LLC
EarthShift Global, LLC
Quantis
Anthesis Group
ERM CVS
The Carbon Trust
China Quality Certification Centre
CTI Certification Co., Ltd.
China Certification and Inspection Group Guangdong Co., Ltd.
Fangyuan Mark Certification Group Co., Ltd.
Guangzhou CEPREI Certification Center Service Co., Ltd.
Korea Testing Certification Institute
Korea Testing Laboratory
SIRIM QAS International Sdn. Bhd.
SGS S.A.
Bureau Veritas SA
TÜV SÜD AG
Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Segment by Type
Product Carbon Footprint Assessment Services
Product Carbon Footprint Verification Services
Product Carbon Footprint Assessment and Verification Integrated Services
Product Carbon Footprint Assessment Support Services
Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Segment by Application
Primary Pharmaceutical Packaging Applications
Secondary Pharmaceutical Packaging Applications
Transport Pharmaceutical Packaging Applications
All Pharmaceutical Packaging Levels
Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging key companies, revenue, market share, and recent developments.
3. To split the Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging significant trends, drivers, influence factors in global and regions.
6. To analyze Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging industry.
Chapter 3: Detailed analysis of Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Product Carbon Footprint Assessment Services
- Product Carbon Footprint Verification Services
- Product Carbon Footprint Assessment and Verification Integrated Services
- Product Carbon Footprint Assessment Support Services
Applications
- Primary Pharmaceutical Packaging Applications
- Secondary Pharmaceutical Packaging Applications
- Transport Pharmaceutical Packaging Applications
- All Pharmaceutical Packaging Levels
Companies covered
- TÜV Rheinland AG
- DNV AS
- UL Solutions Inc.
- BSI Group
- LRQA Group Limited
- DEKRA SE
- RINA S.p.A.
- SCS Global Services
- Intertek Group plc
- Eurofins Scientific SE
- Sphera Solutions, Inc.
- One Click LCA Oy
- Ecochain Technologies B.V.
- Trayak LLC
- EarthShift Global, LLC
- Quantis
- Anthesis Group
- ERM CVS
- The Carbon Trust
- China Quality Certification Centre
- CTI Certification Co., Ltd.
- China Certification and Inspection Group Guangdong Co., Ltd.
- Fangyuan Mark Certification Group Co., Ltd.
- Guangzhou CEPREI Certification Center Service Co., Ltd.
- Korea Testing Certification Institute
- Korea Testing Laboratory
- SIRIM QAS International Sdn. Bhd.
- SGS S.A.
- Bureau Veritas SA
- TÜV SÜD AG
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Market Dynamics
- 2.1 Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Industry Trends
- 2.2 Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Industry Drivers
- 2.3 Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Industry Opportunities and Challenges
- 2.4 Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Industry Restraints
3 Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Market by Company
- 3.1 Global Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Company Revenue Ranking in 2025
- 3.2 Global Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue by Company (2021-2026)
- 3.3 Global Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Company Ranking (2024-2026)
- 3.4 Global Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Company Manufacturing Base and Headquarters
- 3.5 Global Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Company Product Type and Application
- 3.6 Global Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Market by Type
- 4.1 Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Type Introduction
- 4.1.1 Product Carbon Footprint Assessment Services
- 4.1.2 Product Carbon Footprint Verification Services
- 4.1.3 Product Carbon Footprint Assessment and Verification Integrated Services
- 4.1.4 Product Carbon Footprint Assessment Support Services
- 4.2 Global Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value by Type
- 4.2.1 Global Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value by Type (2021-2032)
- 4.2.3 Global Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Share by Type (2021-2032)
5 Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Market by Application
- 5.1 Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Application Introduction
- 5.1.1 Primary Pharmaceutical Packaging Applications
- 5.1.2 Secondary Pharmaceutical Packaging Applications
- 5.1.3 Transport Pharmaceutical Packaging Applications
- 5.1.4 All Pharmaceutical Packaging Levels
- 5.2 Global Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value by Application
- 5.2.1 Global Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value by Application (2021-2032)
- 5.2.3 Global Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Share by Application (2021-2032)
6 Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Regional Value Analysis
- 6.1 Global Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value by Region (2021-2032)
- 6.2.1 Global Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value by Region: 2021-2026
- 6.2.2 Global Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value (2021-2032)
- 6.3.2 North America Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value (2021-2032)
- 6.4.2 Europe Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value (2021-2032)
- 6.6.2 South America Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Share by Country, 2025 VS 2032
7 Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Country-level Value Analysis
- 7.1 Global Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value by Country (2021-2032)
- 7.2.1 Global Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value by Country (2021-2026)
- 7.2.2 Global Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
- 7.7.2 France Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
- 7.14.2 China Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
- 7.17.2 India Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 TÜV Rheinland AG
- 8.1.1 TÜV Rheinland AG Company Information
- 8.1.2 TÜV Rheinland AG Business Overview
- 8.1.3 TÜV Rheinland AG Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 8.1.4 TÜV Rheinland AG Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Product Portfolio
- 8.1.5 TÜV Rheinland AG Recent Developments
- 8.2 DNV AS
- 8.2.1 DNV AS Company Information
- 8.2.2 DNV AS Business Overview
- 8.2.3 DNV AS Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 8.2.4 DNV AS Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Product Portfolio
- 8.2.5 DNV AS Recent Developments
- 8.3 UL Solutions Inc.
- 8.3.1 UL Solutions Inc. Company Information
- 8.3.2 UL Solutions Inc. Business Overview
- 8.3.3 UL Solutions Inc. Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 8.3.4 UL Solutions Inc. Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Product Portfolio
- 8.3.5 UL Solutions Inc. Recent Developments
- 8.4 BSI Group
- 8.4.1 BSI Group Company Information
- 8.4.2 BSI Group Business Overview
- 8.4.3 BSI Group Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 8.4.4 BSI Group Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Product Portfolio
- 8.4.5 BSI Group Recent Developments
- 8.5 LRQA Group Limited
- 8.5.1 LRQA Group Limited Company Information
- 8.5.2 LRQA Group Limited Business Overview
- 8.5.3 LRQA Group Limited Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 8.5.4 LRQA Group Limited Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Product Portfolio
- 8.5.5 LRQA Group Limited Recent Developments
- 8.6 DEKRA SE
- 8.6.1 DEKRA SE Company Information
- 8.6.2 DEKRA SE Business Overview
- 8.6.3 DEKRA SE Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 8.6.4 DEKRA SE Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Product Portfolio
- 8.6.5 DEKRA SE Recent Developments
- 8.7 RINA S.p.A.
- 8.7.1 RINA S.p.A. Company Information
- 8.7.2 RINA S.p.A. Business Overview
- 8.7.3 RINA S.p.A. Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 8.7.4 RINA S.p.A. Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Product Portfolio
- 8.7.5 RINA S.p.A. Recent Developments
- 8.8 SCS Global Services
- 8.8.1 SCS Global Services Company Information
- 8.8.2 SCS Global Services Business Overview
- 8.8.3 SCS Global Services Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 8.8.4 SCS Global Services Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Product Portfolio
- 8.8.5 SCS Global Services Recent Developments
- 8.9 Intertek Group plc
- 8.9.1 Intertek Group plc Company Information
- 8.9.2 Intertek Group plc Business Overview
- 8.9.3 Intertek Group plc Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 8.9.4 Intertek Group plc Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Product Portfolio
- 8.9.5 Intertek Group plc Recent Developments
- 8.10 Eurofins Scientific SE
- 8.10.1 Eurofins Scientific SE Company Information
- 8.10.2 Eurofins Scientific SE Business Overview
- 8.10.3 Eurofins Scientific SE Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 8.10.4 Eurofins Scientific SE Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Product Portfolio
- 8.10.5 Eurofins Scientific SE Recent Developments
- 8.11 Sphera Solutions, Inc.
- 8.11.1 Sphera Solutions, Inc. Company Information
- 8.11.2 Sphera Solutions, Inc. Business Overview
- 8.11.3 Sphera Solutions, Inc. Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 8.11.4 Sphera Solutions, Inc. Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Product Portfolio
- 8.11.5 Sphera Solutions, Inc. Recent Developments
- 8.12 One Click LCA Oy
- 8.12.1 One Click LCA Oy Company Information
- 8.12.2 One Click LCA Oy Business Overview
- 8.12.3 One Click LCA Oy Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 8.12.4 One Click LCA Oy Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Product Portfolio
- 8.12.5 One Click LCA Oy Recent Developments
- 8.13 Ecochain Technologies B.V.
- 8.13.1 Ecochain Technologies B.V. Company Information
- 8.13.2 Ecochain Technologies B.V. Business Overview
- 8.13.3 Ecochain Technologies B.V. Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 8.13.4 Ecochain Technologies B.V. Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Product Portfolio
- 8.13.5 Ecochain Technologies B.V. Recent Developments
- 8.14 Trayak LLC
- 8.14.1 Trayak LLC Company Information
- 8.14.2 Trayak LLC Business Overview
- 8.14.3 Trayak LLC Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 8.14.4 Trayak LLC Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Product Portfolio
- 8.14.5 Trayak LLC Recent Developments
- 8.15 EarthShift Global, LLC
- 8.15.1 EarthShift Global, LLC Company Information
- 8.15.2 EarthShift Global, LLC Business Overview
- 8.15.3 EarthShift Global, LLC Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 8.15.4 EarthShift Global, LLC Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Product Portfolio
- 8.15.5 EarthShift Global, LLC Recent Developments
- 8.16 Quantis
- 8.16.1 Quantis Company Information
- 8.16.2 Quantis Business Overview
- 8.16.3 Quantis Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 8.16.4 Quantis Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Product Portfolio
- 8.16.5 Quantis Recent Developments
- 8.17 Anthesis Group
- 8.17.1 Anthesis Group Company Information
- 8.17.2 Anthesis Group Business Overview
- 8.17.3 Anthesis Group Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 8.17.4 Anthesis Group Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Product Portfolio
- 8.17.5 Anthesis Group Recent Developments
- 8.18 ERM CVS
- 8.18.1 ERM CVS Company Information
- 8.18.2 ERM CVS Business Overview
- 8.18.3 ERM CVS Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 8.18.4 ERM CVS Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Product Portfolio
- 8.18.5 ERM CVS Recent Developments
- 8.19 The Carbon Trust
- 8.19.1 The Carbon Trust Company Information
- 8.19.2 The Carbon Trust Business Overview
- 8.19.3 The Carbon Trust Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 8.19.4 The Carbon Trust Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Product Portfolio
- 8.19.5 The Carbon Trust Recent Developments
- 8.20 China Quality Certification Centre
- 8.20.1 China Quality Certification Centre Company Information
- 8.20.2 China Quality Certification Centre Business Overview
- 8.20.3 China Quality Certification Centre Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 8.20.4 China Quality Certification Centre Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Product Portfolio
- 8.20.5 China Quality Certification Centre Recent Developments
- 8.21 CTI Certification Co., Ltd.
- 8.21.1 CTI Certification Co., Ltd. Company Information
- 8.21.2 CTI Certification Co., Ltd. Business Overview
- 8.21.3 CTI Certification Co., Ltd. Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 8.21.4 CTI Certification Co., Ltd. Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Product Portfolio
- 8.21.5 CTI Certification Co., Ltd. Recent Developments
- 8.22 China Certification and Inspection Group Guangdong Co., Ltd.
- 8.22.1 China Certification and Inspection Group Guangdong Co., Ltd. Company Information
- 8.22.2 China Certification and Inspection Group Guangdong Co., Ltd. Business Overview
- 8.22.3 China Certification and Inspection Group Guangdong Co., Ltd. Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 8.22.4 China Certification and Inspection Group Guangdong Co., Ltd. Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Product Portfolio
- 8.22.5 China Certification and Inspection Group Guangdong Co., Ltd. Recent Developments
- 8.23 Fangyuan Mark Certification Group Co., Ltd.
- 8.23.1 Fangyuan Mark Certification Group Co., Ltd. Company Information
- 8.23.2 Fangyuan Mark Certification Group Co., Ltd. Business Overview
- 8.23.3 Fangyuan Mark Certification Group Co., Ltd. Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 8.23.4 Fangyuan Mark Certification Group Co., Ltd. Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Prod
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst